Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

101 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Long-term outcomes after unrelated donor transplantation for severe sickle cell disease on the BMT CTN 0601 trial.
Eapen M, Kou J, Andreansky M, Bhatia M, Brochstein J, Chaudhury S, Haight AE, Haines H, Jacobsohn D, Jaroscak J, Kasow KA, Krishnamurti L, Levine JE, Leung K, Margolis D, Yu LC, Horowitz MM, Kamani N, Walters MC, Shenoy S. Eapen M, et al. Among authors: kamani n. Am J Hematol. 2024 Apr;99(4):785-788. doi: 10.1002/ajh.27251. Epub 2024 Feb 11. Am J Hematol. 2024. PMID: 38343182 No abstract available.
Long-Term Immune Reconstitution in ADA-Deficient Patients Treated With Elapegademase: A Real-World Experience.
Murguia-Favela L, Suresh S, Wright NAM, Alvi S, Tehseen S, Hernandez-Trujillo V, Seroogy CM, Haddad E, Nieves D, Hershfield MS, Walter JE, Pettiford L, Kamani NR, Keller MD, Pham-Huy A, Grunebaum E. Murguia-Favela L, et al. Among authors: kamani nr. J Allergy Clin Immunol Pract. 2023 Jun;11(6):1725-1733. doi: 10.1016/j.jaip.2023.01.028. Epub 2023 Feb 1. J Allergy Clin Immunol Pract. 2023. PMID: 36736953
Granulocyte Colony-Stimulating Factor Is Safe and Well Tolerated following Allogeneic Transplantation in Patients with Sickle Cell Disease.
Shah NC, Bhoopatiraju S, Abraham A, Anderson E, Andreansky M, Bhatia M, Chaudhury S, Cuvelier GDE, Godder K, Grimley M, Hale G, Kamani N, Jacobsohn D, Ngwube A, Gilman AL, Skiles J, Yu LC, Shenoy S. Shah NC, et al. Among authors: kamani n. Transplant Cell Ther. 2022 Mar;28(3):174.e1-174.e5. doi: 10.1016/j.jtct.2021.12.016. Epub 2021 Dec 24. Transplant Cell Ther. 2022. PMID: 34958973 Free article. Clinical Trial.
Correction: Impact of autologous blood transfusion after bone marrow harvest on unrelated donor's health and outcome: a CIBMTR analysis.
Farhadfar N, Murthy HS, Logan BR, Sees JA, Ayas M, Battiwalla M, Beitinjaneh AM, Chhabra S, Diaz MA, Engles K, Frangoul H, Ganguly S, Gergis U, Kamani NR, Kamble RT, Kasow KA, Lazarus HM, Liesveld JL, Norkin M, O' Donnell PV, Olsson RF, Rossmann S, Savani BN, Schears R, Seo S, Solh MM, Spitzer T, Sugrue M, Yared JA, Linenberger M, Schwartz J, Pulsipher MA, Shah NN, Switzer GE, Confer DL, Shaw BE, Wingard JR. Farhadfar N, et al. Among authors: kamani nr. Bone Marrow Transplant. 2021 Feb;56(2):522. doi: 10.1038/s41409-020-0963-9. Bone Marrow Transplant. 2021. PMID: 32514157 Free PMC article. No abstract available.
Subsequent neoplasms and late mortality in children undergoing allogeneic transplantation for nonmalignant diseases.
Kahn JM, Brazauskas R, Tecca HR, Bo-Subait S, Buchbinder D, Battiwala M, Flowers MED, Savani BN, Phelan R, Broglie L, Abraham AA, Keating AK, Daly A, Wirk B, George B, Alter BP, Ustun C, Freytes CO, Beitinjaneh AM, Duncan C, Copelan E, Hildebrandt GC, Murthy HS, Lazarus HM, Auletta JJ, Myers KC, Williams KM, Page KM, Vrooman LM, Norkin M, Byrne M, Diaz MA, Kamani N, Bhatt NS, Rezvani A, Farhadfar N, Mehta PA, Hematti P, Shaw PJ, Kamble RT, Schears R, Olsson RF, Hayashi RJ, Gale RP, Mayo SJ, Chhabra S, Rotz SJ, Badawy SM, Ganguly S, Pavletic S, Nishihori T, Prestidge T, Agrawal V, Hogan WJ, Inamoto Y, Shaw BE, Satwani P. Kahn JM, et al. Among authors: kamani n. Blood Adv. 2020 May 12;4(9):2084-2094. doi: 10.1182/bloodadvances.2019000839. Blood Adv. 2020. PMID: 32396620 Free PMC article.
Impact of autologous blood transfusion after bone marrow harvest on unrelated donor's health and outcome: a CIBMTR analysis.
Farhadfar N, Murthy HS, Logan BR, Sees JA, Ayas M, Battiwalla M, Beitinjaneh AM, Chhabra S, Diaz MA, Engles K, Frangoul H, Ganguly S, Gergis U, Kamani NR, Kamble RT, Kasow KA, Lazarus HM, Liesveld JL, Norkin M, O' Donnell PV, Olsson RF, Rossmann S, Savani BN, Schears R, Seo S, Solh MM, Spitzer T, Sugrue M, Yared JA, Linenberger M, Schwartz J, Pulsipher MA, Shah NN, Switzer GE, Confer DL, Shaw BE, Wingard JR. Farhadfar N, et al. Among authors: kamani nr. Bone Marrow Transplant. 2020 Nov;55(11):2121-2131. doi: 10.1038/s41409-020-0911-8. Epub 2020 Apr 30. Bone Marrow Transplant. 2020. PMID: 32355289 Free PMC article.
Worldwide Network for Blood and Marrow Transplantation (WBMT) recommendations for establishing a hematopoietic cell transplantation program (Part I): Minimum requirements and beyond.
Pasquini MC, Srivastava A, Ahmed SO, Aljurf M, Atsuta Y, Doleysh C, Galeano S, Gluckman E, Greinix H, Hale G, Hari P, Hashmi SK, Kamani N, Laughlin MJ, Niederwieser D, Seber A, Szer J, Snowden JA, Van Biesen K, Watry P, Weisdorf DJ, Apperley J. Pasquini MC, et al. Among authors: kamani n. Hematol Oncol Stem Cell Ther. 2020 Sep;13(3):131-142. doi: 10.1016/j.hemonc.2019.08.001. Epub 2019 Aug 20. Hematol Oncol Stem Cell Ther. 2020. PMID: 31449780 Free PMC article.
Worldwide Network for Blood and Marrow Transplantation Recommendations for Establishing a Hematopoietic Cell Transplantation Program, Part I: Minimum Requirements and Beyond.
Pasquini MC, Srivastava A, Ahmed SO, Aljurf M, Atsuta Y, Doleysh C, Galeano S, Gluckman E, Greinix H, Hale GA, Hari P, Hashmi SK, Kamani N, Laughlin MJ, Niederwieser D, Seber A, Szer J, Snowden JA, Van Biesen K, Watry P, Weisdorf DJ, Apperley J. Pasquini MC, et al. Among authors: kamani n. Biol Blood Marrow Transplant. 2019 Dec;25(12):2322-2329. doi: 10.1016/j.bbmt.2019.05.002. Epub 2019 May 6. Biol Blood Marrow Transplant. 2019. PMID: 31071457 Free article. Review.
Functional and Radiologic Assessment of the Brain after Reduced-Intensity Unrelated Donor Transplantation for Severe Sickle Cell Disease: Blood and Marrow Transplant Clinical Trials Network Study 0601.
King AA, McKinstry RC, Wu J, Eapen M, Abel R, Varughese T, Kamani N, Shenoy S. King AA, et al. Among authors: kamani n. Biol Blood Marrow Transplant. 2019 May;25(5):e174-e178. doi: 10.1016/j.bbmt.2019.01.008. Epub 2019 Jan 11. Biol Blood Marrow Transplant. 2019. PMID: 30639825 Free PMC article. Clinical Trial.
101 results